BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 33254222)

  • 1. Cardiovascular mortality and cardiovascular event rates in patients with inflammatory rheumatic diseases in the CARdiovascular in rheuMAtology (CARMA) prospective study-results at 5 years of follow-up.
    Martín-Martínez MA; Castañeda S; Sánchez-Alonso F; García-Gómez C; González-Juanatey C; Sánchez-Costa JT; Belmonte-López MA; Tornero-Molina J; Santos-Rey J; Sánchez González CO; Quesada E; Moreno-Gil MP; Cobo-Ibáñez T; Pinto-Tasnde JA; Babío-Herráez J; Bonilla G; Juan-Mas A; Manero-Ruiz FJ; Romera-Baurés M; Bachiller-Corral J; Chamizo-Carmona E; Uriarte-Ecenarro M; Barbadillo C; Fernández-Carballido C; Aurrecoechea E; Möller-Parrera I; Llorca J; González-Gay MA;
    Rheumatology (Oxford); 2021 Jun; 60(6):2906-2915. PubMed ID: 33254222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of first cardiovascular event in Spanish patients with inflammatory rheumatic diseases: prospective data from the CARMA project.
    Martín-Martínez MA; Castañeda S; González-Juanatey C; Sánchez-Alonso F; García-Gómez C; López-González R; Babío-Herraiz J; Juan-Mas A; Moreno-Gil MP; Sánchez-González CO; Romera-Baurés M; Pinto-Tasende JA; Tornero-Molina J; Fábregas-Canales D; Llorca J; González-Gay MA;
    Clin Exp Rheumatol; 2019; 37(5):731-739. PubMed ID: 30620291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular morbidity and associated risk factors in Spanish patients with chronic inflammatory rheumatic diseases attending rheumatology clinics: Baseline data of the CARMA Project.
    Castañeda S; Martín-Martínez MA; González-Juanatey C; Llorca J; García-Yébenes MJ; Pérez-Vicente S; Sánchez-Costa JT; Díaz-Gonzalez F; González-Gay MA;
    Semin Arthritis Rheum; 2015 Jun; 44(6):618-26. PubMed ID: 26058345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D deficiency in chronic inflammatory rheumatic diseases: results of the cardiovascular in rheumatology [CARMA] study.
    Urruticoechea-Arana A; Martín-Martínez MA; Castañeda S; Piedra CA; González-Juanatey C; Llorca J; Díaz-Gonzalez F; González-Gay MA;
    Arthritis Res Ther; 2015 Aug; 17(1):211. PubMed ID: 26271333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular risk profiles in a hospital-based population of patients with psoriatic arthritis and ankylosing spondylitis: a cross-sectional study.
    Nissen CB; Hørslev-Petersen K; Primdahl J
    Rheumatol Int; 2017 Jan; 37(1):113-120. PubMed ID: 27889826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biologics and cardiovascular events in inflammatory arthritis: a prospective national cohort study.
    Lee JL; Sinnathurai P; Buchbinder R; Hill C; Lassere M; March L
    Arthritis Res Ther; 2018 Aug; 20(1):171. PubMed ID: 30086795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory rheumatic diseases and the risk of drug use disorders: a register-based cohort study in Sweden.
    Kiadaliri A; Dell'Isola A; Englund M
    Clin Rheumatol; 2024 Jan; 43(1):81-85. PubMed ID: 37639149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review.
    Horreau C; Pouplard C; Brenaut E; Barnetche T; Misery L; Cribier B; Jullien D; Aractingi S; Aubin F; Joly P; Le Maître M; Ortonne JP; Paul C; Richard MA
    J Eur Acad Dermatol Venereol; 2013 Aug; 27 Suppl 3():12-29. PubMed ID: 23845149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and Management of Cardiovascular Risk Factors in Psoriatic Arthritis and Rheumatoid Arthritis: A Population-Based Study.
    Jafri K; Bartels CM; Shin D; Gelfand JM; Ogdie A
    Arthritis Care Res (Hoboken); 2017 Jan; 69(1):51-57. PubMed ID: 27696731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis.
    Peters MJ; Symmons DP; McCarey D; Dijkmans BA; Nicola P; Kvien TK; McInnes IB; Haentzschel H; Gonzalez-Gay MA; Provan S; Semb A; Sidiropoulos P; Kitas G; Smulders YM; Soubrier M; Szekanecz Z; Sattar N; Nurmohamed MT
    Ann Rheum Dis; 2010 Feb; 69(2):325-31. PubMed ID: 19773290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and risk factors of major cardiovascular events in rheumatoid arthritis and psoriatic arthritis: A population-based cohort study.
    Meng H; Lam SH; So H; Tam LS
    Semin Arthritis Rheum; 2024 Apr; 65():152416. PubMed ID: 38368730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis associated with an increased risk of cardiovascular events? A prospective nationwide population-based cohort study.
    Bengtsson K; Forsblad-d'Elia H; Lie E; Klingberg E; Dehlin M; Exarchou S; Lindström U; Askling J; Jacobsson LTH
    Arthritis Res Ther; 2017 May; 19(1):102. PubMed ID: 28521824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined use of QRISK3 and SCORE2 increases identification of ankylosing spondylitis patients at high cardiovascular risk: Results from the CARMA Project cohort after 7.5 years of follow-up.
    Polo Y la Borda J; Castañeda S; Sánchez-Alonso F; Plaza Z; García-Gómez C; Ferraz-Amaro I; Erausquin C; Valls-García R; Fábregas MD; Delgado-Frías E; Mas AJ; González-Juanatey C; Llorca J; González-Gay MA;
    Semin Arthritis Rheum; 2024 Jun; 66():152442. PubMed ID: 38555727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical profile and outcome of patients with chronic inflammatory arthritis and metabolic syndrome.
    Cioffi G; Viapiana O; Tarantini L; Orsolini G; Idolazzi L; Sonographer FO; Dalbeni A; Gatti D; Fassio A; Rossini M; Giollo A
    Intern Emerg Med; 2021 Jun; 16(4):863-874. PubMed ID: 33083946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Body Mass Index and Disease Activity in Chronic Inflammatory Rheumatic Diseases: Results of the Cardiovascular in Rheumatology (Carma) Project.
    Valero-Jaimes JA; López-González R; Martín-Martínez MA; García-Gómez C; Sánchez-Alonso F; Sánchez-Costa JT; González-Juanatey C; Revuelta-Evrad E; Díaz-Torné C; Fernández-Espartero C; Pérez-García C; Torrente-Segarra V; Sánchez-Nievas G; Pérez-Sandoval T; Font-Ugalde P; García-Vivar ML; Aurrecoechea E; Maiz-Alonso O; Valls-García R; Miranda-Filloy JA; Llorca J; Castañeda S; Gonzalez-Gay MA
    J Clin Med; 2021 Jan; 10(3):. PubMed ID: 33498379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular events in early RA are a result of inflammatory burden and traditional risk factors: a five year prospective study.
    Innala L; Möller B; Ljung L; Magnusson S; Smedby T; Södergren A; Öhman ML; Rantapää-Dahlqvist S; Wållberg-Jonsson S
    Arthritis Res Ther; 2011 Aug; 13(4):R131. PubMed ID: 21843325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of risk chart algorithms for the identification of psoriatic arthritis patients at high risk for cardiovascular disease: findings derived from the project CARMA cohort after a 7.5-year follow-up period.
    Polo Y La Borda J; Castañeda S; Heras-Recuero E; Sánchez-Alonso F; Plaza Z; García Gómez C; Ferraz-Amaro I; Sanchez-Costa JT; Sánchez-González OC; Turrión-Nieves AI; Perez-Alcalá A; Pérez-García C; González-Juanatey C; Llorca J; Gonzalez-Gay MA;
    RMD Open; 2024 Apr; 10(2):. PubMed ID: 38631846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular Event Risk in Rheumatoid Arthritis Compared with Type 2 Diabetes: A 15-year Longitudinal Study.
    Agca R; Hopman LHGA; Laan KJC; van Halm VP; Peters MJL; Smulders YM; Dekker JM; Nijpels G; Stehouwer CDA; Voskuyl AE; Boers M; Lems WF; Nurmohamed MT
    J Rheumatol; 2020 Mar; 47(3):316-324. PubMed ID: 31092721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular risk factors predicting cardiac events are different in patients with rheumatoid arthritis, psoriatic arthritis, and psoriasis.
    Cooksey R; Brophy S; Kennedy J; Gutierrez FF; Pickles T; Davies R; Piguet V; Choy E
    Semin Arthritis Rheum; 2018 Dec; 48(3):367-373. PubMed ID: 29656791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Five-year cardiovascular event risk in early rheumatoid arthritis patients who received treat-to-target management: a case-control study.
    Lam TO; Cheng IT; Lam SH; Mok CC; Ho CT; Cheung TT; Lao VW; Pang HT; To CH; Yim CW; Ng A; Kwok KY; Lee KL; Ying SK; Wan MC; Lee JM; Tam LS
    Rheumatology (Oxford); 2023 Sep; 62(9):2998-3005. PubMed ID: 36707997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.